# Oral Dexamethasone for the Management of Symptomatic Irreversible Pulpitis Without Performing Pulpotomy

> **NCT05761730** · PHASE1 · UNKNOWN · sponsor: **May Samaha** · enrollment: 80 (estimated)

## Conditions studied

- Irreversible Pulpitis

## Interventions

- **DRUG:** Dexamethasone Oral

## Key facts

- **NCT ID:** NCT05761730
- **Lead sponsor:** May Samaha
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-15
- **Primary completion:** 2023-06
- **Final completion:** 2023-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05761730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05761730, "Oral Dexamethasone for the Management of Symptomatic Irreversible Pulpitis Without Performing Pulpotomy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05761730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*